ESR1 and breast carcinoma: At lower concentrations (<10 μM), phytoestrogens, such as genistein, acted as ligand of ERs and stimulated metabolic pathways, which in turn induced ER-positive MCF-7 cells proliferation, but not the ER-negative MDA-MB-231 breast cancer cells.